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What is virus chikungunya? 
Chikungunya virus (CHIKV) is an emerging pathogen that belongs to the 
Togaviridae family. It causes chikungunya fever (CHIKF), a febrile illness 
associated with arthralgia and rash. The name chikungunya derives from 
a word in Makonde (Bantu language) meaning “that which bends,” 
describing the stooped appearance of those people suffering the 
characteristic painful arthralgia. Although in most cases this virus is not 
severe, it has become a global threat due to the emergence in recent 
years of several outbreaks that have affected a large part of the 
population and to the lack of effective vaccines and antivirals [1].  
The chikungunya virus is divided into three distinct lineages [2] : 
 West African lineage. 
 Eastern / Central / Southern Africa lineage (ECSA). This group 
emerged a new lineage, the lineage of the Indian Ocean (IOL). 
 Asian lineage.  
Transmission Dynamics  
 
 
 
 
 
Clinical manifestations  
 
 
 
 
 
 
 
 
 
 
Fever (↑39ºC) 
Polyarthralgias 
Headache 
Myalgias 
Back pain Nausea 
Vomiting 
Rash  
Polyarthritis  
Conjunctivitis 
3% - 28%  
↓ 
asymptomatic 
infections  
 
Symptoms can last for 
3-10 days but joint 
pain may persist for 
months  
 
Mortality ↓↓ 
Treatment and vaccines 
• There is no specific antiviral drug treatment for CHIKV.  
• Treatment is symptomatic and is based on treating manifestations 
that appear during infection. In addition, patients are advised to 
drink plenty of fluids [3].  
• Absence of an effective CHIKV vaccine. 
Prevention and Control [5] 
In the absence of an effective CHIKV vaccine, the only tool available to 
prevent infection is the reduction of human-vector contact. 
 Use mosquito repellents on exposed skin or clothing. 
 Wear long-sleeved shirts and long trousers.  
 Should use Insecticide-treated bednets. 
 Activate programs for vector control  
• Reduce natural and artificial water tanks 
• Using insecticides  
CHIKV is transmitted by the bite 
of mosquitoes of genus Aedes. 
There are two main vectors of 
CHIKV, A. aegypti and A. 
albopictus [3]. 
Risk factors for virus introduction 
 The vector is present in region.  
 Presence of individuals sensitive to CHIKV who have never been 
exposed to this virus.  
 The arrival of travellers infected with CHIKV.  
 
   Epidemiology[4] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chikungunya virus was insolated for the first 
time in Tanzania in 1953, where there was an 
outbreak during 1952-1953.  
ECSA genotype 
1 
Between 1960-1970 there were large 
outbreaks in Thailand and India.  
Asian genotype 
2 
2 
In 2004, the CHIKV explodes 
worldwide producing a series 
of devastating outbreaks 
affecting up to 6.5 million of 
people. It emerged in Kenya in 
2004 and spread to several 
islands in the Indian Ocean, 
India and Southeast Asia.  
ECSA genotype - IOL lineage 
3 
3 
3 
In 2007 the first local outbreak came into Europe, particularly into Italy. It 
was introduced by a viremic traveler returning from India.  
ECSA genotype - IOL lineage 
4 
In 2013, autochthonous 
transmission was first 
detected in American Region. 
This outbreak has spread 
rapidly throughout the 
Caribbean and South 
America.  
776.000 suspected cases until 
October 2014, have been 
reported with 152 deaths. In 
recent years the United 
States, Mexico and Europe 
have been of detecting 
imported cases of viremics 
coming from areas with 
epidemic transmission.  
Asian genotype 
5 
Conclusions  
Chikungunya virus has remained endemic in Africa and South-East Asia, but there 
was a series of outbreaks in other regions of the world where the virus is not 
endemic. 
The fact that this virus is transmitted by a vector, mosquito Aedes, and there are no 
effective vaccines the only tool available to prevent infection is to reduce human – 
vector contact.  
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Figure 1. Aedes aegypti and Aedes albopictus. Images obtained from 
http://www.cdc.gov/chikungunya/transmission/. 
Figura 2 . Symptoms of Chikungunya fever.  Modified from: 
http://www1.paho.org/hq/dmdocuments/CHIKV_Spanish.pdf [3] 
 
Figure 3. The most 
important outbreaks.  
Image obtained from: 
https://lacasadelpoio.wor
dpress.com/2007/06/19/
mapamundi/  
  
